# Therapeutic pulpotomy for permanent teeth with irreversible pulpitis: comparative results from a practice-based quick poll in the USA and UK

## TL;DR

A survey of dentists in the USA and UK shows growing interest in using therapeutic pulpotomy for irreversible pulpitis in permanent teeth, though root canal therapy remains the most common treatment.

## Contribution

This study reveals current clinical practices and attitudes toward therapeutic pulpotomy for irreversible pulpitis among dental practitioners in the USA and UK.

## Key findings

- Root canal therapy is the most common treatment for irreversible pulpitis in both the USA and UK.
- Therapeutic pulpotomy is reported as a treatment strategy by 20% of USA and 16% of UK respondents.
- A larger proportion of dentists in both countries are willing to consider pulpotomy as a definitive treatment.

## Abstract

Treatment paradigms for teeth with signs and symptoms of irreversible pulpitis in permanent teeth are evolving, with increasing interest in conservative approaches such as therapeutic pulpotomy. Understanding the perspectives of both general dentists and endodontists is essential to defining current clinical practices and informing future research. This study explored dental practitioners’ approaches to the diagnosis and management of irreversible pulpitis, with a focus on the use of pulpotomy as a definitive treatment.

An online “Quick Poll” cross-sectional survey was distributed to dental practitioners in the United States via the National Dental Practice-Based Research Network and in the United Kingdom through open online channels, including local dental networks, practice-based research networks, and social media platforms.

A total of 750 practitioners responded (USA: 416; UK: 334), most of whom were general dental practitioners with over 10 years of experience. Irreversible pulpitis was most diagnosed in 1–5 patients per month. Root canal therapy was the predominant treatment in both countries (USA: 77%; UK: 90%), with extraction frequently selected in the UK (50%). Pulpotomy was reported as a treatment strategy by 20% of USA and 16% of UK respondents, though a larger proportion expressed willingness to consider it as a definitive option (USA: 47%; UK: 87%).

This preliminary study highlights the growing interest in therapeutic pulpotomy as a definitive treatment for teeth with signs and symptoms of irreversible pulpitis in permanent teeth in primary care. Differences in clinical adoption and attitudes between the USA and UK suggest opportunities for further research, education, and implementation support to facilitate the integration of vital pulp therapies into routine practice.